The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5
Bo Han(Emory University), Shi‐Yong Sun(Emory University)
Cited by 43
Related Papers
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
|Signal Transduction and Targeted Therapy|2022|767
Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
|Cancer Research|2008|159
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
|Journal of Biological Chemistry|2010|98
Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation
|Journal of Biological Chemistry|2015|98